A correlation between the titre of circulating IgG autoantibodies and disease activity has been difficult to demonstrate in bullous pemphigoid. We postulate that isotype switching from "inflammatory" IgG1 to "blocking" IgG4 subclass antibodies might contribute to disease remission. We studied 16 patients with bullous pemphigoid, 3 patients with cicatricial pemphigoid and 2 patients with epidermolysis bullosa acquisita at different stages of the disease. The titres of IgG subclass and total IgG basement membrane zone autoantibodies were correlated with clinical activity. Ten of the 16 bullous pemphigoid patients went into remission. The total IgG autoantibody levels showed variable changes. IgG1 autoantibody decreased in 7 patients (3 were u...
Pemphigus is a severe autoimmune disease characterized by circulating and bound in vivo pemphigus au...
Autoimmune bullous diseases are a group of cutaneous disorders characterised by skin blistering or e...
Bullous pemphigoid was first described by Lever in 1953 as a subepidermal blistering disease. Its im...
BACKGROUND: Autoantibodies to the extracellular domain (ECD) of bullous pemphigoid (BP) antigen 180 ...
A marvel of evolution, the adaptive immune system has the capacity to respond to almost any foreign ...
Bullous pemphigoid (BP) is a prototypical organ-specific autoimmune disease. Autoantibodies unfold t...
Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The unde...
Bullous pemphigoid is associated with antibodies to a 230 kDa and a 180 kDa protein. In a literature...
Bullous pemphigoid (BP), the most common autoimmune subepidermal bullous disease, is associated with...
Bullous pemphigoid (BP), the most common autoimmune subepidermal bullous disease, is associated with...
Bullous pemphigoid (BP), a blistering dermopathy, is a prototypic antibody‐mediated disease. Detecti...
Pemphigus is a severe autoimmune disease characterized by circulating and bound in vivo pemphigus au...
Organ-specific autoimmunity is often characterized by autoantibodies targeting proteins expressed in...
Organ-specific autoimmunity is often characterized by autoantibodies targeting proteins expressed in...
We describe three patients who initially presented with both clinical and immunological findings to ...
Pemphigus is a severe autoimmune disease characterized by circulating and bound in vivo pemphigus au...
Autoimmune bullous diseases are a group of cutaneous disorders characterised by skin blistering or e...
Bullous pemphigoid was first described by Lever in 1953 as a subepidermal blistering disease. Its im...
BACKGROUND: Autoantibodies to the extracellular domain (ECD) of bullous pemphigoid (BP) antigen 180 ...
A marvel of evolution, the adaptive immune system has the capacity to respond to almost any foreign ...
Bullous pemphigoid (BP) is a prototypical organ-specific autoimmune disease. Autoantibodies unfold t...
Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The unde...
Bullous pemphigoid is associated with antibodies to a 230 kDa and a 180 kDa protein. In a literature...
Bullous pemphigoid (BP), the most common autoimmune subepidermal bullous disease, is associated with...
Bullous pemphigoid (BP), the most common autoimmune subepidermal bullous disease, is associated with...
Bullous pemphigoid (BP), a blistering dermopathy, is a prototypic antibody‐mediated disease. Detecti...
Pemphigus is a severe autoimmune disease characterized by circulating and bound in vivo pemphigus au...
Organ-specific autoimmunity is often characterized by autoantibodies targeting proteins expressed in...
Organ-specific autoimmunity is often characterized by autoantibodies targeting proteins expressed in...
We describe three patients who initially presented with both clinical and immunological findings to ...
Pemphigus is a severe autoimmune disease characterized by circulating and bound in vivo pemphigus au...
Autoimmune bullous diseases are a group of cutaneous disorders characterised by skin blistering or e...
Bullous pemphigoid was first described by Lever in 1953 as a subepidermal blistering disease. Its im...